PI
STRO icon

PEAK6 Investments’s Sutro Biopharma STRO Stock Holding History

PEAK6 Investments’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$39.1K Buy
+1,131
New +$44.3K ﹤0.01% 3142

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PEAK6 Investments's STRO Position: Q3 2024 in Review

PEAK6 Investments opened a new position in Sutro Biopharma (STRO) in Q3 2024: 1,131 shares worth $39.1K. The stake represents ﹤0.01% of the portfolio and ranks #3142 among its holdings.

130 funds tracked by Wall St. Rank hold STRO as of Q3 2024.

  • PEAK6 Investments held 1,131 shares of Sutro Biopharma worth $39.1K as of Q3 2024.
  • Sutro Biopharma was a new PEAK6 Investments position in Q3 2024.
  • Sutro Biopharma made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #3142 holding.
  • 130 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.